MaxCyte Inc Forecast, price target & analysts
MaxCyte Inc Target price 2025 - Analyst rating & recommendation
MaxCyte Inc Classifications & Recommendation:
MaxCyte Inc Price Target
| Target Price | $5.83 |
| Price | $1.55 |
| Potential |
276.41%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target MaxCyte Inc 2026 .
The average MaxCyte Inc target price is $5.83.
This is
276.41%
register free of charge
$9.45
509.68%
register free of charge
$5.05
225.81%
register free of charge
|
|
| A rating was issued by 13 analysts: 10 Analysts recommend MaxCyte Inc to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MaxCyte Inc stock has an average upside potential 2026 of
276.41%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 38.63 | 37.13 |
| 6.44% | 3.88% | |
| EBITDA Margin | -121.80% | -89.60% |
| 13.50% | 26.43% | |
| Net Margin | -106.29% | -123.95% |
| 15.74% | 16.61% |
9 Analysts have issued a sales forecast MaxCyte Inc 2025 . The average MaxCyte Inc sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an MaxCyte Inc EBITDA forecast 2025. The average MaxCyte Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 MaxCyte Inc Analysts have issued a net profit forecast 2025. The average MaxCyte Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.39 | -0.43 |
| 5.41% | 10.26% | |
| P/E | negative | |
| EV/Sales | 1.04 |
9 Analysts have issued a MaxCyte Inc forecast for earnings per share. The average MaxCyte Inc EPS is
This results in the following potential growth metrics and future valuations:
Current MaxCyte Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
| William Blair |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BTIG:
Locked
➜
Locked
|
Aug 11 2025 |
|
Locked
William Blair:
Locked
➜
Locked
|
Aug 07 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Mar 12 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
